Foot and Mouth Disease Vaccine Market

Foot and Mouth Disease Vaccine Market (Type: Aluminum Hydroxide and Saponin Vaccines and Oil-based Vaccines; and Animal: Cattle, Sheep and Goat, Swine/Pig, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2023-2031

Global Foot and Mouth Disease Vaccine Market Outlook

  • The global industry was valued at US$ 1.4 Bn in 2022
  • It is projected to grow at a CAGR of 5.9% from 2023 to 2031 and surpass US$ 2.4 Bn by the end of 2031

Analysts’ Viewpoint on Market Scenario

The foot and mouth disease vaccine market size is expected to increase at a steady pace in the next few years due to rise in number of foot and mouth disease (FMD) outbreaks. Increase in demand for livestock products is also projected to boost market expansion in the near future.

Rise in demand for animal protein, surge in government initiatives to control FMD outbreaks, and increase in awareness about animal health are propelling the demand for FMD vaccines. Animal protein is gaining traction among the populace due to changes in dietary habits and increase in disposable income.

FMD virus is highly contagious and outbreaks can cause significant economic losses due to restrictions on the movement of livestock and animal products. Thus, governments across the globe are focused on controlling FMD outbreaks. India and Brazil are implementing FMD control programs to prevent the spread of the disease.

Key players are developing advanced and effective FMD vaccines, including recombinant vaccines, virus-like particle vaccines, and synthetic peptide vaccines. They are also investing in improving the vaccine production process and expanding their distribution networks to broaden their customer base.

Foot And Mouth Disease Vaccine Market

Market Introduction

Foot and mouth disease (FMD) is a highly contagious viral disease that affects cloven-hoofed animals, including cattle, pigs, sheep, goats, and deer. The disease causes significant economic losses due to decreased milk and meat production, death of infected animals, and trade restrictions. Vaccines are widely used to prevent the spread of FMD in countries where the disease is endemic or where there is a high risk of outbreaks.

The global foot and mouth disease vaccine industry includes both oil-based and aluminum hydroxide-based vaccines. Oil-based vaccines are more commonly used due to their longer-lasting immunity and fewer booster requirements.

Livestock products are gaining traction worldwide. The demand for animal products in emerging countries, such as India and Brazil, is expected to more than double by 2030. Thus, governments and vendors are seeking robust vaccines to prevent any FMD outbreaks that can affect livestock production.

Increase in Government Initiatives for Control and Eradication of FMDs Boosting Foot and Mouth Disease Vaccine Market Development

Government initiatives play a vital role in the control and eradication of FMDs during an outbreak and during the time of routine vaccination. FMD-endemic countries and regions are constantly implementing various programs to control and eradicate the disease.

In 2019, the Food and Agriculture Organization (FAO) and the World Organization for Animal Health launched the Progressive Control Pathway for FMD (PCP-FMD). The program aims to help countries improve their FMD control measures, including the distribution of vaccines. The PCP-FMD provides a step-by-step approach for countries to progressively improve their FMD control measures, with the ultimate goal of achieving FMD-free status. Thus, implementation of various FMD control and eradication programs is expected to spur the foot and mouth disease vaccine market growth in the near future.

FMD is a highly contagious disease and spreads rapidly from one animal to another within a short time. Therefore, countries that are threatened by sudden outbreaks of viral infection are taking specific initiatives to control FMD outbreaks. They are investing significantly in routine vaccination to completely eradicate FMD from their respective regions. Such initiatives are driving the foot and mouth disease vaccine market value.

Frequent FMD Outbreaks in Asia Pacific and Middle East & Africa

Several FMD outbreaks have occurred, worldwide, in the past few years, affecting livestock populations and causing economic losses. In May 2022, an outbreak of FMD was reported in cattle in Indonesia. It was the first outbreak since the country was declared FMD-free in 1986.

The Government of Indonesia launched a nationwide rollout of vaccinations in mid-June. It also restricted the movement of livestock and launched a campaign to educate farmers on the risks of FMD. Thus, repeated outbreaks of FMD cases in Asia Pacific and Middle East & Africa are augmenting the foot and mouth disease vaccine market trajectory.

High Demand for Oil-based Vaccines

According to the latest foot and mouth disease vaccine market trends, the oil-based vaccines type segment is expected to dominate the industry during the forecast period. Oil-based FMD vaccines provide long-term immunity against multiple FMD virus strains. These vaccines contain a killed virus that is emulsified in oil, which allows for a slow release of the virus and a longer duration of immunity.

Oil-based vaccines are more thermally stable than other types of FMD vaccines, which means they can withstand a wider range of temperatures during transport and storage without losing their potency. Additionally, these vaccines offer cross-protection against different FMD virus serotypes, meaning they can protect against multiple strains of the virus with a single vaccine. This is particularly important in regions where there are multiple circulating strains of FMD virus, as it can be difficult and expensive to produce individual vaccines for each strain. Oil-based vaccines are also considered safe and effective for use in pregnant animals, which is an important factor in maintaining a healthy livestock population.

Extensive Use of FMD Vaccines in Cattle

According to the latest foot and mouth disease vaccine market analysis, the cattle animal segment is projected to hold major share from 2023 to 2031. FMD affects cloven-hoofed animals, including cattle, pigs, sheep, goats, and buffalo. However, cattle are particularly susceptible to FMD due to their high levels of viral replication and shedding. They also can remain asymptomatic carriers of the virus for extended periods of time.

Use of cattle for dairy and beef production is a significant contributor to the global economy. Outbreaks of FMD can have a significant impact on trade and exports, as several countries have stringent import regulations on animals and animal products from FMD-endemic countries. Therefore, there is a significant financial incentive for farmers, producers, and governments to invest in FMD vaccines for cattle.

Surge in Demand for FMD Vaccines in Government Institutions

According to the latest foot and mouth disease vaccine market research, the government institutions distribution channel segment is estimated to dominate the industry during the forecast period.

Government institutions are one of the major distribution channels for FMD vaccines due to several reasons. Firstly, FMD is a highly contagious viral disease that affects cloven-hoofed animals. This makes it a significant public health concern, and governments are often responsible for controlling and preventing its spread. Consequently, governments play a critical role in the distribution of FMD vaccines and are often the primary purchasers of vaccines for their livestock populations.

Secondly, government institutions have a wide network of distribution channels that allows them to reach a large number of livestock farmers and producers. Governments often have established veterinary departments and agencies that oversee the distribution and administration of vaccines to livestock populations. They also have the resources to develop and implement vaccination programs, which may include mass vaccination campaigns or targeted vaccination programs in areas where outbreaks are occurring.

Regional Outlook

According to the latest foot and mouth disease vaccine market forecast, Asia Pacific is anticipated to hold largest share from 2023 to 2031. The region accounted for the largest share in 2022. Presence of a large population of livestock and growth in the agriculture sector are fueling market dynamics in the region.

Several countries in Asia Pacific, such as China, India, and South Korea, have a well-established agricultural sector. Governments in these countries are actively implementing programs to control the spread of FMD, including vaccination campaigns. Rise in the export of livestock products is also driving market statistics in the region. China, India, and Hong Kong are one of the major exporters of beef and pork to the Americas and Europe.

Surge in investment in animal health programs, which include the development and use of FMD vaccines, is projected to augment market progress in Latin America during the forecast period. The Pan American Foot-and-Mouth Disease Center (PANAFTOSA) in Brazil has been at the forefront of FMD vaccine development and production in the region.

Implementation of various regulations and vaccination programs to control and eradicate FMD, with support from the World Organization for Animal Health (OIE), is also boosting the market revenue in Latin America.

Rise in outbreaks of FMD is likely to fuel the foot and mouth disease vaccine market share of Middle East & Africa in the near future. FMD is endemic in many parts of the region, with frequent outbreaks occurring due to various factors such as the presence of multiple FMD virus serotypes, inadequate biosecurity measures, and movement of animals across borders. These outbreaks can lead to significant economic losses, making FMD vaccination a priority for governments and farmers in Middle East & Africa.

Analysis of Key Players

The global industry is fragmented, with the presence of several foot and mouth disease vaccine manufacturers including BVI, Indian Immunologicals Ltd, Ceva Santé Animale, MEVAC, National Veterinary Institute, Limor de Colombia SAS, Brilliant Bio Pharma, VETAL Animal Health Products, Inc., Biogénesis Bagó, Kenya Veterinary Vaccines Production Institute, Boehringer Ingelheim International GmbH, Zoetis, Inc., and Ourofino Saúde Animal.

Key players in the foot and mouth disease vaccine market report have been profiled based on various parameters such as company overview, financial overview, business strategies, product portfolio, business segments, and recent developments.

Key Developments

  • In October 2022, Indian Immunologicals (IIL) announced an investment of approximately INR 700 crores to establish a new animal vaccine manufacturing facility in Genome Valley, Hyderabad. The facility is likely to focus on the production of vaccines for FMD and other emerging diseases.
  • In June 2021, The Pirbright Institute, in Surrey, England, reported the discovery of previously unknown sections of the FMD virus that can activate an immune response, providing valuable insights for the development of more effective vaccines

Global Foot and Mouth Disease Vaccine Market Snapshot

Attribute

Detail

Market Size in 2022

US$ 1.4 Bn

Market Forecast Value in 2031

More than US$ 2.4 Bn

CAGR

5.9%

Forecast Period

2023-2031

Historical Data Available for

2017-2021

Quantitative Units

US$ Bn for Value

Market Analysis

It includes segment analysis as well as regional level analysis. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, Porter’s Five Forces analysis, value chain analysis, and key trend analysis.

Competition Landscape

  • Market share analysis by company (2022)
  • Company profiles section includes overview, product portfolio, sales footprint, key subsidiaries or distributors, strategy & recent developments, and key financials

Format

Electronic (PDF) + Excel

Segmentation

  • Type
    • Aluminum Hydroxide and Saponin Vaccines
    • Oil-based Vaccines
      • Single-oil Emulsion
      • Double-oil Emulsion
  • Animal
    • Cattle
    • Sheep and Goat
    • Swine / Pig
    • Others
  • Distribution Channel
    • Veterinary Clinics
    • Government Institutions
    • Others

Regions Covered

  • Asia Pacific
  • Latin America
  • Middle East & Africa
  • Rest of the World

Countries Covered

  • China
  • India
  • Japan
  • Australia & New Zealand
  • Brazil
  • Mexico
  • GCC Countries
  • South Africa
  • Other

Companies Profiled

  • BVI
  • Indian Immunologicals Ltd.
  • Ceva Santé Animale
  • MEVAC
  • National Veterinary Institute
  • Limor de Colombia SAS
  • Brilliant Bio Pharma
  • VETAL Animal Health Products, Inc.
  • Biogénesis Bagó
  • Kenya Veterinary Vaccines Production Institute
  • Boehringer Ingelheim International GmbH
  • Zoetis, Inc.
  • Ourofino Saúde Animal
  • Other Prominent Players

Frequently Asked Questions

How big was the global foot and mouth disease vaccine market in 2022?

The global market was valued at US$ 1.4 Bn in 2022

How big will the foot and mouth disease vaccine industry be in 2031?

It is projected to surpass a value of US$ 2.4 Bn by the end of 2031

What will be the CAGR of the foot and mouth disease vaccine business during the forecast period?

It is anticipated to be 5.9% from 2023 to 2031

Which foot and mouth disease vaccine segment held largest share?

The oil-based vaccines type segment held more than 60.0% share in 2022

Which region is likely to record the highest demand for foot and mouth disease vaccines during the forecast period?

Asia Pacific is expected to record highest demand from 2023 to 2031

Who are the prominent foot and mouth disease vaccine manufacturers?

BVI, Indian Immunologicals Ltd, Ceva Santé Animale, MEVAC, National Veterinary Institute, Limor de Colombia SAS, Brilliant Bio Pharma, VETAL Animal Health Products, Inc., Biogénesis Bagó, Kenya Veterinary Vaccines Production Institute, Boehringer Ingelheim International GmbH, Zoetis, Inc., and Ourofino Saúde Animal

    1. Preface

        1.1. Market Definition and Scope

        1.2. Market Segmentation

        1.3. Key Research Objectives

        1.4. Research Highlights

    2. Assumptions and Research Methodology

    3. Executive Summary: Global Foot and Mouth Disease Vaccine Market

    4. Market Overview

        4.1. Introduction

            4.1.1. Segment Definition

        4.2. Overview

        4.3. Market Dynamics

            4.3.1. Drivers

            4.3.2. Restraints

            4.3.3. Opportunities

        4.4. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, 2017-2031

            4.4.1. Market Revenue Projections (US$ Bn)

    5. Key Insights

        5.1. Foot and Mouth Disease Overview

        5.2. Disease Prevalence & Incidence Rate Overview

        5.3. Regulatory Scenario

        5.4. Key Industry Events

        5.5. COVID-19 Pandemic Impact on Industry (Value Chain and Short/Mid/Long-term Impact)

    6. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Type

        6.1. Introduction & Definition

        6.2. Key Findings/Developments

        6.3. Market Value Forecast, by Type, 2017-2031

            6.3.1. Aluminum Hydroxide and Saponin Vaccines

            6.3.2. Oil-based Vaccines

                6.3.2.1. Single-oil Emulsion

                6.3.2.2. Double-oil Emulsion

        6.4. Market Attractiveness, by Type

    7. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Animal

        7.1. Introduction & Definition

        7.2. Key Findings/Developments

        7.3. Market Value Forecast, by Animal, 2017-2031

            7.3.1. Cattle

            7.3.2. Sheep and Goat

            7.3.3. Swine/Pig

            7.3.4. Others

        7.4. Market Attractiveness, by Animal

    8. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Distribution Channel

        8.1. Introduction & Definition

        8.2. Key Findings/Developments

        8.3. Market Value Forecast, by Distribution Channel, 2017-2031

            8.3.1. Veterinary Clinics

            8.3.2. Government Institutions

            8.3.3. Others

        8.4. Market Attractiveness, by Distribution Channel

    9. Global Foot and Mouth Disease Vaccine Market Analysis and Forecast, by Region

        9.1. Key Findings

        9.2. Market Value Forecast, by Region

            9.2.1. Asia Pacific

            9.2.2. Latin America

            9.2.3. Middle East & Africa

            9.2.4. Rest of the World

        9.3. Market Attractiveness, by Country/Region

    10. Asia Pacific Foot and Mouth Disease Vaccine Market Analysis and Forecast

        10.1. Introduction

            10.1.1. Key Findings

        10.2. Market Value Forecast, by Type, 2017-2031

            10.2.1. Aluminum Hydroxide and Saponin Vaccines

            10.2.2. Oil-based Vaccines

                10.2.2.1. Single-oil Emulsion

                10.2.2.2. Double-oil Emulsion

        10.3. Market Value Forecast, by Animal, 2017-2031

            10.3.1. Cattle

            10.3.2. Sheep and Goat

            10.3.3. Swine/Pig

            10.3.4. Others

        10.4. Market Value Forecast, by Distribution Channel, 2017-2031

            10.4.1. Veterinary Clinics

            10.4.2. Government Institutions

            10.4.3. Others

        10.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            10.5.1. China

            10.5.2. India

            10.5.3. Rest of Asia Pacific

        10.6. Market Attractiveness Analysis

            10.6.1. By Type

            10.6.2. By Animal

            10.6.3. By Distribution Channel

            10.6.4. By Country/Sub-region

    11. Latin America Foot and Mouth Disease Vaccine Market Analysis and Forecast

        11.1. Introduction

            11.1.1. Key Findings

        11.2. Market Value Forecast, by Type, 2017-2031

            11.2.1. Aluminum Hydroxide and Saponin Vaccines

            11.2.2. Oil-based Vaccines

                11.2.2.1. Single-oil Emulsion

                11.2.2.2. Double-oil Emulsion

        11.3. Market Value Forecast, by Animal, 2017-2031

            11.3.1. Cattle

            11.3.2. Sheep and Goat

            11.3.3. Swine/Pig

            11.3.4. Others

        11.4. Market Value Forecast, by Distribution Channel, 2017-2031

            11.4.1. Veterinary Clinics

            11.4.2. Government Institutions

            11.4.3. Others

        11.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            11.5.1. Brazil

            11.5.2. Argentina

            11.5.3. Rest of Latin America

        11.6. Market Attractiveness Analysis

            11.6.1. By Type

            11.6.2. By Animal

            11.6.3. By Distribution Channel

            11.6.4. By Country/Sub-region

    12. Middle East & Africa Foot and Mouth Disease Vaccine Market Analysis and Forecast

        12.1. Introduction

            12.1.1. Key Findings

        12.2. Market Value Forecast, by Type, 2017-2031

            12.2.1. Aluminum Hydroxide and Saponin Vaccines

            12.2.2. Oil-based Vaccines

                12.2.2.1. Single-oil Emulsion

                12.2.2.2. Double-oil Emulsion

        12.3. Market Value Forecast, by Animal, 2017-2031

            12.3.1. Cattle

            12.3.2. Sheep and Goat

            12.3.3. Swine/Pig

            12.3.4. Others

        12.4. Market Value Forecast, by Distribution Channel, 2017-2031

            12.4.1. Veterinary Clinics

            12.4.2. Government Institutions

            12.4.3. Others

        12.5. Market Value Forecast, by Country/Sub-region, 2017-2031

            12.5.1. GCC Countries

            12.5.2. South Africa

            12.5.3. Rest of Middle East & Africa

        12.6. Market Attractiveness Analysis

            12.6.1. By Type

            12.6.2. By Animal

            12.6.3. By Distribution Channel

            12.6.4. By Country/Sub-region

    13. Rest of the World Foot and Mouth Disease Vaccine Market Analysis and Forecast

        13.1. Introduction

            13.1.1. Key Findings

        13.2. Market Value Forecast, by Type, 2017-2031

            13.2.1. Aluminum Hydroxide and Saponin Vaccines

            13.2.2. Oil-based Vaccines

                13.2.2.1. Single-oil Emulsion

                13.2.2.2. Double-oil Emulsion

        13.3. Market Value Forecast, by Animal, 2017-2031

            13.3.1. Cattle

            13.3.2. Sheep and Goat

            13.3.3. Swine/Pig

            13.3.4. Others

        13.4. Market Value Forecast, by Distribution Channel, 2017-2031

            13.4.1. Veterinary Clinics

            13.4.2. Government Institutions

            13.4.3. Others

        13.5. Market Attractiveness Analysis

            13.5.1. By Type

            13.5.2. By Animal

            13.5.3. By Distribution Channel

    14. Competition Landscape

        14.1. Market Player - Competition Matrix (By Tier and Size of companies)

        14.2. Company Profiles

            14.2.1. BVI

                14.2.1.1. Company Overview

                14.2.1.2. Financial Overview

                14.2.1.3. Product Portfolio

                14.2.1.4. Business Strategies

                14.2.1.5. Recent Developments

            14.2.2. Indian Immunologicals Ltd.

                14.2.2.1. Company Overview

                14.2.2.2. Financial Overview

                14.2.2.3. Product Portfolio

                14.2.2.4. Business Strategies

                14.2.2.5. Recent Developments

            14.2.3. Ceva Santé Animale

                14.2.3.1. Company Overview

                14.2.3.2. Financial Overview

                14.2.3.3. Product Portfolio

                14.2.3.4. Business Strategies

                14.2.3.5. Recent Developments

            14.2.4. MEVAC

                14.2.4.1. Company Overview

                14.2.4.2. Financial Overview

                14.2.4.3. Product Portfolio

                14.2.4.4. Business Strategies

                14.2.4.5. Recent Developments

            14.2.5. National Veterinary Institute

                14.2.5.1. Company Overview

                14.2.5.2. Financial Overview

                14.2.5.3. Product Portfolio

                14.2.5.4. Business Strategies

                14.2.5.5. Recent Developments

            14.2.6. Limor de Colombia SAS

                14.2.6.1. Company Overview

                14.2.6.2. Financial Overview

                14.2.6.3. Product Portfolio

                14.2.6.4. Business Strategies

                14.2.6.5. Recent Developments

            14.2.7. Brilliant Bio Pharma

                14.2.7.1. Company Overview

                14.2.7.2. Financial Overview

                14.2.7.3. Product Portfolio

                14.2.7.4. Business Strategies

                14.2.7.5. Recent Developments

            14.2.8. VETAL Animal Health Products, Inc.

                14.2.8.1. Company Overview

                14.2.8.2. Financial Overview

                14.2.8.3. Product Portfolio

                14.2.8.4. Business Strategies

                14.2.8.5. Recent Developments

            14.2.9. Biogénesis Bagó

                14.2.9.1. Company Overview

                14.2.9.2. Financial Overview

                14.2.9.3. Product Portfolio

                14.2.9.4. Business Strategies

                14.2.9.5. Recent Developments

            14.2.10. Kenya Veterinary Vaccines Production Institute

                14.2.10.1. Company Overview

                14.2.10.2. Financial Overview

                14.2.10.3. Product Portfolio

                14.2.10.4. Business Strategies

                14.2.10.5. Recent Developments

            14.2.11. Boehringer Ingelheim International GmbH

                14.2.11.1. Company Overview

                14.2.11.2. Financial Overview

                14.2.11.3. Product Portfolio

                14.2.11.4. Business Strategies

                14.2.11.5. Recent Developments

            14.2.12. Zoetis, Inc.

                14.2.12.1. Company Overview

                14.2.12.2. Financial Overview

                14.2.12.3. Product Portfolio

                14.2.12.4. Business Strategies

                14.2.12.5. Recent Developments

            14.2.13. Ourofino Saúde Animal

                14.2.13.1. Company Overview

                14.2.13.2. Financial Overview

                14.2.13.3. Product Portfolio

                14.2.13.4. Business Strategies

                14.2.13.5. Recent Developments

    List of Tables

    Table 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

    Table 02: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

    Table 03: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

    Table 04: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

    Table 05: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Region, 2017-2031

    Table 06: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

    Table 07: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

    Table 08: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

    Table 09: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

    Table 10: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

    Table 11: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

    Table 12: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

    Table 13: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

    Table 14: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

    Table 15: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

    Table 16: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

    Table 17: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

    Table 18: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

    Table 19: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

    Table 20: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Country/Sub-region, 2017-2031

    Table 21: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Type, 2017-2031

    Table 22: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Oil-based Vaccines, 2017-2031

    Table 23: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Animal, 2017-2031

    Table 24: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, by Distribution Channel, 2017-2031

    List of Figures

    Figure 01: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

    Figure 02: Foot and Mouth Disease Vaccine Market Value Share, by Type, 2022

    Figure 03: Foot and Mouth Disease Vaccine Market Value Share, by Animal, 2022

    Figure 04: Foot and Mouth Disease Vaccine Market Value Share, by Distribution Channel, 2022

    Figure 05: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

    Figure 06: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

    Figure 07: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Aluminum Hydroxide and Saponin Vaccines, 2017‒2031

    Figure 08: Global Foot and Mouth Disease Vaccine Market Value (US$ Bn), by Oil-based Vaccines, 2017‒2031

    Figure 09: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

    Figure 10: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

    Figure 11: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Cattle, 2017-2031

    Figure 12: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Sheep and Goat, 2017-2031

    Figure 13: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Swine/Pig, 2017-2031

    Figure 14: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031

    Figure 15: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 16: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

    Figure 17: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Veterinary Clinics, 2017-2031

    Figure 18: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Government Institutions, 2017-2031

    Figure 19: Global Foot and Mouth Disease Vaccine Market Revenue (US$ Bn), by Others, 2017-2031

    Figure 20: Global Foot and Mouth Disease Vaccine Market Value Share Analysis, by Region, 2022 and 2031

    Figure 21: Global Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Region, 2023-2031

    Figure 22: Asia Pacific Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

    Figure 23: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

    Figure 24: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

    Figure 25: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

    Figure 26: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

    Figure 27: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 28: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

    Figure 29: Asia Pacific Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 30: Asia Pacific Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 31: Latin America Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

    Figure 32: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

    Figure 33: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

    Figure 34: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

    Figure 35: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

    Figure 36: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 37: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

    Figure 38: Latin America Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 39: Latin America Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 40: Middle East & Africa Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

    Figure 41: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

    Figure 42: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

    Figure 43: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

    Figure 44: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

    Figure 45: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 46: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

    Figure 47: Middle East & Africa Foot and Mouth Disease Vaccine Market Value Share Analysis, by Country/Sub-region, 2022 and 2031

    Figure 48: Middle East & Africa Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Country/Sub-region, 2023-2031

    Figure 49: Rest of the World Foot and Mouth Disease Vaccine Market Value (US$ Bn) Forecast, 2017-2031

    Figure 50: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Type, 2022 and 2031

    Figure 51: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Type, 2023-2031

    Figure 52: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Animal, 2022 and 2031

    Figure 53: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Animal, 2023-2031

    Figure 54: Rest of the World Foot and Mouth Disease Vaccine Market Value Share Analysis, by Distribution Channel, 2022 and 2031

    Figure 55: Rest of the World Foot and Mouth Disease Vaccine Market Attractiveness Analysis, by Distribution Channel, 2023-2031

Copyright © Transparency Market Research, Inc. All Rights reserved